COVID-19 Newsletter (vol. 68) by Center for Disaster Medicine, New York Medical College
Touro Scholar 
COVID-19 Newsletter NYMC Archives Publications 
4-20-2021 
COVID-19 Newsletter (vol. 68) 
Center for Disaster Medicine, New York Medical College 
Follow this and additional works at: https://touroscholar.touro.edu/nymc_covid19_newsletter 









Tuesday, April 20, 2021 
 
 
During this COVID-19 pandemic and other future events, the CDM has been 
and will continue to be a source of reliable information, education and models 
for mitigation, preparedness, response, and recovery.  We hope this 
informational document has helped provide you filtered and actionable 
information.  As the pace of new information and changes occur, we will 
evaluate the current once per week to determine if this information should be 
provided on a more frequent basis.   
 
 
                                                                                                                        
David Markenson, M.D., M.B.A. 
Director 






 Total Cases Total Deaths Total Recovered Total Tested 
Worldwide 142,112,632 3,030,299 81,325,274 Not Available 
United States 31,738,228 567,694 Not Available 417,360,348 
New Jersey 981,036 25,161 Not Available 13,034,835 
New York 2,003,938 51,627 Not Available 48,960,229 
Connecticut 331,401 8,014 Not Available 7,697,168 
 
Information as of 4/20/21 at 0000 EDT. Source: https://coronavirus.jhu.edu/map.html  
 







Center for Disaster Medicine Updates 
 
● Collaborated with NYMC medical students and on April 6, 2021, presented at NYMC Medical 
Student Research Seminar regarding “Drawing Parallels between Public Health Crises and 
COVID-19” 
● Delivered Geriatric Emergency Medical Services (GEMS) course to members of different 
public safety agencies from New York. 
● Presented invited lecture regarding COVID-19 response and best practices to graduate 
students enrolled in Master in Homeland Security degree in Guatemala. 
● Coordinating and overseeing COVID-19 screenings at NYMC campus 
● Continue to partner with local organizations such as Westchester Department of Emergency 
Services and Westchester Medical Center to ensure ongoing collaboration with all public 
safety agencies. 
● Coordinating volunteers to support local public health response to COVID-19. 
● Conducting research and analysis of current events and COVID-19 response to identify 
strengths and areas for improvement in other regions. 
● Updating and developing new programs to provide enhanced education on public health 
emergencies including pandemics. 
● Exploring course development opportunities in infection prevention and control for frontline 
responders in the hospital and in the field. 
● Serving as a source of information for COVID-19 related concerns or questions regarding 
public health, emergency medical service (EMS), public safety and healthcare response.  
● Local networking and pandemic response analysis for New York’s tri-state area, using first-
person experiences to highlight current trends. 
 
To view the Center for Disaster Medicine's newest webinar, please click here - The 





• The White House released a report on the potential for inflation with respect to the COVID-
19 pandemic and how it will impact daily living. The report noted, “in the next several months 
we expect measured inflation to increase somewhat, primarily due to three different 
temporary factors: base effects, supply chain disruptions, and pent-up demand, especially 
for services. We expect these three factors will likely be transitory, and that their impact 
should fade over time as the economy recovers from the pandemic. After that, the longer-
term trajectory of inflation is in large part a function of inflationary expectations. Here, too, we 




The White House  
 
As part of President Biden’s continued efforts to ensure the pandemic response reaches all 
people and all communities, the Biden Administration  announced it will invest more than $4 





The official website of the White House delivers bold action and immediate relief for American 
families as the country grapples with converging crises. This includes actions to control the 
COVID-19 pandemic, provide economic relief, tackle climate change, and advance racial equity 
and civil rights, as well as immediate actions to reform our immigration system and restore 




Health and Human Services (HHS) 
 
The U.S. Department of Health and Human Services (HHS) announced the availability of nearly 
$150 million to community-based health care providers to aid their response to COVID-19. 
These funds will support approximately 100 Health Center Program look-alikes to respond to 
and mitigate the spread of COVID-19, strengthen vaccination efforts, and enhance health care 
services and infrastructure in communities across the country. Health center look-alikes (LALs) 
are community-based health care providers that provide essential primary care services to 
underserved communities and vulnerable populations but are not Health Center Program 
grantees. This funding will be made available through the Health Resources and Services 
Administration (HRSA) and is part of President Biden's commitment to ensuring equity in the 




On April 16, COVID-19 Health Equity Chair, Marcella Nunez-Smith, M.D.,convened the second 
COVID-19 Health Equity Task Force to discuss the Biden-Harris Administration’s whole-of-
society approach to mitigate the health inequities caused or exacerbated by the COVID-19 
pandemic and for preventing such inequities in the future. This meeting specifically covered 













The National Institutes of Health will fund a large, randomized, placebo‑controlled Phase 3 
clinical trial to test several existing prescription and over-the-counter medications for people to 
self-administer to treat symptoms of COVID-19. Part of the Accelerating COVID‑19 Therapeutic 
Interventions and Vaccines (ACTIV) public–private partnership, the ACTIV-6 trial aims to provide 
evidence-based treatment options for the majority of adult patients with COVID-19 who have 
mild-to-moderate symptoms and are not sick enough to be hospitalized. NIH will provide an 




The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease 
damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study 
from National Institutes of Health scientists. SARS-CoV-2 is the virus that causes COVID-19. 
MK-4482, delivered orally, is now in human clinical trials. Remdesivir, an antiviral drug already 
approved by the U.S. Food and Drug Administration for use against COVID-19, must be 




The National Institutes of Health is awarding up to $33 million over two years to fund projects at 
10 institutions across eight states to build evidence on safely returning students, teachers and 
support staff to in-person school in areas with vulnerable and underserved populations. This 
funding was made available by the American Rescue Plan. Known as the Safe Return to School 
Diagnostic Testing Initiative, the awards are part of the NIH Rapid Acceleration of Diagnostics 
Underserved Populations (RADx-UP) program, which aims to increase COVID-19 testing access 
and uptake for vulnerable and underserved populations. Projects will combine frequent COVID-





The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of 
Health, today announced that the fourth iteration of the Adaptive COVID-19 Treatment Trial 
(ACTT-4) has closed to enrollment because the study met pre-defined futility criteria indicating 
that neither treatment regimen studied is likely significantly better than the other. The NIAID-
sponsored trial aimed to determine which of two drug combinations—baricitinib plus remdesivir 
or dexamethasone plus remdesivir — was more effective at preventing adults hospitalized with 
COVID-19 on supplemental oxygen from progressing to requiring mechanical ventilation or 








United States Food and Drug Administration (FDA) 
 
As of April 16, 2021, 363 tests and sample collection devices are authorized by the FDA 
under emergency use authorizations (EUAs). These include 266 molecular tests and 
sample collection devices, 75 antibody and other immune response tests, and 22 antigen 
tests. There are 46 molecular authorizations and one antibody authorization that can be 
used with home-collected samples. There is one molecular prescription at-home test, two 
antigen prescription at-home tests, four over-the-counter (OTC) at-home antigen tests, 
and two OTC molecular tests. The FDA has authorized 7 antigen tests and 2 molecular 





The U.S. Food and Drug Administration revoked the emergency use authorization (EUA) 
that allowed for the investigational monoclonal antibody therapy bamlanivimab, when 
administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults 
and certain pediatric patients. Based on its ongoing analysis of emerging scientific data, 
specifically the sustained increase of SARS-CoV-2 viral variants that are resistant to 
bamlanivimab alone resulting in the increased risk for treatment failure, the FDA has 
determined that the known and potential benefits of bamlanivimab, when administered 
alone, no longer outweigh the known and potential risks for its authorized use. Therefore, 
the agency determined that the criteria for issuance of an authorization are no longer met 








Centers for Disease Control and Prevention (CDC) 
COVID-19 vaccines are effective. However, a small percentage of people who are fully 
vaccinated will still get COVID-19 if they are exposed to the virus that causes it. These 
are called “vaccine breakthrough cases.” This means that while people who have been 
vaccinated are much less likely to get sick, it may still happen. Experts continue to study 




The emerging variants CDC is closely monitoring have mutations in the virus genome that 
alter the characteristics and cause the virus to act differently in ways that are significant to 
public health (e.g., causes more severe disease, spreads more easily between humans, 
requires different treatments, changes the effectiveness of current vaccines). It’s 
important to understand that genetic mutations are expected, and some variants can 
spread and become predominant while others subside. 
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html  
 
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and 
trends of COVID-19 in the United States- updated daily by 8 p.m. ET. 
https://covid.cdc.gov/covid-data-tracker/#datatracker-home  
 
For the latest CDC information 
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html 
 
Center for Medicare and Medicaid Services (CMS)   






In this section, vaccine-related information from various sources will be collected, 
reviewed, and tabulated here.  As of April 20, 2021, the FDA has granted Emergency Use 
Authorization (EUA) to Pfizer BioNTech, Moderna and Janssen/Johnson & Johnson. Now 
with three vaccines with EUA, the goal is to vaccinate a larger number of persons in the 
coming months throughout the United States. As additional vaccines are granted EUA, 
information for those vaccines will also be included. CDC provides update on “How to talk 
about COVID-19 vaccines with friends and family.” COVID-19 vaccines are new, and it’s 
normal to for people to have questions about them. The sheer amount of information—
and misinformation—about COVID-19 vaccines can be overwhelming to anyone.  
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/talk-about-vaccines.html  
 
CDC created this section regarding COVID-19 vaccinations in the United States. CDC 
provides overall U.S. COVID-19 Vaccine, deliveries and administration, maps, charts, and 
data updated daily by 8 p.m.. This section represents all vaccine partners including 
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal 
Emergency Management Agency and Health Resources and Services Administration 
partner sites, and federal entity facilities.  
https://covid.cdc.gov/covid-data-tracker/#vaccinations  
 
Effective April 19, 2021, CDC announced that everyone 16 years of age and older is now 
eligible to get a COVID-19 vaccination. Get a COVID-19 vaccine as soon as you can. 
Widespread vaccination is a critical tool to help stop the pandemic. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/How-Do-I-Get-a-COVID-19-
Vaccine.htmlA joint media briefing with the U.S. Centers for Disease Control and 
Prevention and the U.S. Food and Drug Administration to discuss six reported cases of a 
rare type of blood clot in individuals who received the Janssen COVID-19 Vaccine.  
https://www.cdc.gov/media/releases/2021/a0413-jj-vaccine.html  
 
On April 13, 2021, CDC and FDA recommended a pause in the use of Johnson & 
Johnson’s Janssen COVID-19 Vaccine. Of the nearly 7 million doses administered so far 
in the United States, a small number of reports of a rare and severe type of blood clot 
have been reported in people after receiving the J&J/Janssen COVID-19 Vaccine.  All 
reports occurred among women between the ages of 18 and 48, and symptoms occurred 
six to 13 days after vaccination. As of April 13, 2021, of the more than 180 million doses 
administered so far of the Pfizer-BioNTech or Moderna vaccines, no reports matching 
those associated with the J&J/Janssen vaccine have been received. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/JJUpdate.html  
 
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide 
updated relevant information including side effects and safety data, clinical trials 
demographic statistics, and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html  
 
CDC created this section regarding the Moderna vaccine to provide updated relevant 
information including side effects and safety data, clinical trials demographic statistics, 
and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html   
 
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated 
relevant information including side effects and safety data, clinical trials demographic 




HHS created this section to provide the latest information about COVID-19 vaccines. 
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html  
 
On April 19, 2021, Governor Andrew M. Cuomo updated New Yorkers on the state's 
vaccination program. 131,589 doses have been administered across the state's vast 
distribution network in the last 24 hours, and nearly 1.4 million doses have been 




The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the 
distribution of the vaccine including the number of doses received by the state, a 
breakdown of first or second doses, and the number of persons vaccinated with the first 
and second doses in each region. 
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker  
 
NYS DOH releases instructions for New York State-operated vaccination sites 
https://covid19vaccine.health.ny.gov/  
 
NYC DOHMH provides 2021 Health Alert #6 regarding Cases of Cerebral Venous Sinus 





For NYC DOHMH updated guidance regarding COVID-19 vaccine 
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page  
 
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19 
vaccination location. The Vaccine Finder can also provide New Yorkers with information 




Educational Institution Information 
• Higher Education 
o A bill allowing students to record class sessions for the purpose of 
lodging free speech and other complaints is likely to become law in 
Florida. The bill, which sailed through Florida’s House of Representatives 
and Senate, says that a student may record video or audio of class 
lectures not only for their own personal educational use but also “in 
connection with a complaint to the public institution of higher education 
where the recording was made, or as evidence in, or in preparation for, a 
criminal or civil proceeding.” A recorded lecture may not be published 
without the consent of the lecturer, and these recordings must follow 
federal student privacy laws, the bill says. The possible penalty for 




o Kindergarten students, who did not enroll or attend schooling in 
noticeable numbers during the pandemic, are expected to have larger 
participation rates next school year, and school systems are planning 
now to meet these young learners' needs. In fact, some education 
experts are predicting a “kindergarten bubble” of 4-, 5- and 6-year-olds 
who may be more unprepared for formal schooling compared to past 
years’ cohorts, and who will come to school with a wider range of skills 
based on their COVID-19 academic and social experiences.Typically, 
preschool and kindergarten are filled with hands-on, play-based activities 
that not only support early reading and math skills, but also introduce vital 
social and emotional skills such as sharing, turn-taking and resolving 
conflicts, according to early childhood education experts. But when the 
pandemic forced those experiences online unnaturally, many families 
decided to delay enrollment or attendance in formal schooling. In 






To view the latest information on clinical trials regarding COVID-19 
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=  










• Governor Andrew M. Cuomo announced that spectators will be allowed at horse and 
auto races at 20 percent capacity, beginning Thursday, April 22. Spectators will be 
subject to the State's strict guidance, which is currently in effect for other professional 
sports competitions with fans. Attendees must show proof of a recent negative test or 
completed vaccination series prior to entry and are subject to the State's health and 
safety protocols on face coverings, social distancing, and health screening. The 
Governor also announced that the curfew for food and beverage establishments will be 
moved from 11 p.m. to midnight effective Monday, April 19. The curfew for catered 
events will move from midnight to 1 a.m. https://www.governor.ny.gov/news/governor-
cuomo-announces-spectators-will-be-allowed-horse-and-auto-races-20-percent-capacity  
• Governor Cuomo announced that applications are now being accepted for the $26.6 
million available to support essential workers and first responders through the Empire 
Pandemic Response Reimbursement Fund program. The program, coordinated by the 
New York State Office of Children and Family Services, is designed to reimburse out-of-
pocket child or dependent care, transportation, lodging and other qualifying expenses 
that eligible workers incurred while employed in New York State between March 1, 2020, 
through the date of application submission. Up to $1,000 is available per household. The 
funding comes from private donations from individuals, charitable trusts and 
businesses made during the COVID crisis. https://www.governor.ny.gov/news/governor-
cuomo-announces-applications-now-being-accepted-266-million-empire-pandemic-grant  
 
New York State Department of Health (DOH) 
 
For a list of positive cases by county in New York State 
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-
Map?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n  
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information 
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down 
cases by county.  
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-
Map?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n  








• Governor Phil Murphy signed into law A-5445, which provides $10 million in federal 
COVID-19 relief aid for childcare providers throughout New Jersey. The bill – sponsored 
by Senators M. Teresa Ruiz and Joseph Lagana and Assembly Members Lisa Swain, 
Gabriela Mosquera, and Adam Taliaferro – will provide grants to childcare providers in 
need. The bill is part of a five-bill, $100 million relief effort aimed at helping New Jersey’s 
economy recover from the year-long 
pandemic. https://www.nj.gov/governor/news/news/562021/approved/20210413b.shtml  
• Governor Murphy signed Executive Order No. 235. The Order extends the Public Health 
Emergency that was declared on March 9, 2020 through Executive Order No. 103, 
which was previously extended in 2020 on April 7, May 6, June 4, July 2, August 
1, August 27, September 25, October 24, November 22, and December 21, and again in 
2021 on January 19, February 17, and March 17. Under the Emergency Health Powers 




• Governor Ned Lamont, along with Lt. Governor Susan Bysiewicz and Consumer 
Protection Commissioner Michelle Seagull, announced that the Connecticut Department 
of Consumer Protection (DCP) has published a step-by-step informational guide to 
pursuing a career in the skilled trades that aims to promote a more diverse workforce, 
and support women and historically disadvantaged groups in finding stable employment 
and higher wages as Connecticut recovers from the economic downturn of the COVID-








Local Updates  
 
New York Blood Center (NYBC) 
 
For the latest updated NYBC information about COVID-19: 
https://nybc.org/covid-19/  
 
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)   
 
For NYC DOHMH updated COVID-19 data page 
https://www1.nyc.gov/site/doh/covid/covid-19-data.page  
 
For the latest COVID-19 information from NYC DOHMH 
https://www1.nyc.gov/site/doh/covid/covid-19-main.page  
 
Westchester County Department of Health 
 
For the latest breakdown of positive cases in Westchester County as of April 18, 2021 
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d  
 
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams 
offering earlier access to vaccines. 
https://health.westchestergov.com/2019-novel-coronavirus  
 
Putnam County Department of Health 
Breakdown of positive cases by towns in Putnam County as of April 16, 2021- 
https://www.putnamcountyny.com/covid19/  
 
For the latest COVID-19 information 
https://www.putnamcountyny.com/health/coronavirus/ 
 
Dutchess County Department of Health 
 
Breakdown of positive cases in Dutchess County as of April 19, 2021 
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm  
 
For the latest COVID-19 information: 
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm 
 
Orange County Department of Health 
 
Updated COVID-19 dashboard for Orange County, NY as of April 19, 2021 
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71 




Rockland County Department of Health 
 
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of 
April 19, 2021 
https://rockland-covid-19-portal-rockland.hub.arcgis.com/  
 





The House passed legislation (H.R. 1868) last week to extend the moratorium on the two percent 
across-the-board Medicare payment cuts—also known as Medicare sequestration cuts—to all 
providers that serve Medicare patients through the end of 2021. President Joe Biden signed it into 




For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital 





Center for Disaster Medicine Media 
 
New York Medical College Leadership News: 
NYMC disaster response center awarded $1M from state 
The Business Journal 
4/14/2021 
https://westfaironline.com/135149/nymc-disaster-response-center-awarded-1m-from-state/ 
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice 
president for government affairs  
  
New York Medical College Center of Excellence in Precision Responses to Bioterrorism 





Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice 
president for government affairs  
David S. Markenson, M.D., M.B.A., medical director of the Center for Disaster Medicine 
 





Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice 
president for government affairs  
  
New York Medical College News: 










Every effort is made to provide accurate and complete information in this newsletter. However, New 
York Medical College cannot guarantee that there will be no errors. NYMC makes no claims, promises or 
guarantees about the accuracy, completeness, or adequacy of the contents of the newsletters or the 
articles linked herein and further expressly disclaims liability for errors and omissions in the contents of 
this newsletter.  
 
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the 







New York Medical College 
Center for Disaster Medicine 
7 Dana Road Suite 511 
Valhalla, New York 10595 
914-594-1750 
https://www.nymc.edu/center-for-disaster-medicine/ 
 
 
 
 
 
 
